Literature DB >> 1326723

Adenosine 5'-monophosphate transport across the membrane of synaptosomes and myelin.

R P Shank1.   

Abstract

Synaptosome-enriched preparations from rat and guinea pig brain tissue vigorously accumulated [3H]-adenosine 5'-monophosphate ([3H]AMP). When the accumulation of [3H]AMP was determined using incubation periods of 30 s or less, high concentrations of adenosine, dipyridamole and soluflazine did not inhibit the accumulation of label appreciably. The accumulation of [3H]AMP was saturable, temperature-dependent, osmotic-sensitive and exhibited structural specificity. Based on the kinetics of uptake by different subcellular fractions, and the inhibitory effects of other nucleotides, the uptake of AMP appeared to be mediated by three saturable systems with Kt values of approximately 0.2, 6, and 100 microM. The transport system with the highest affinity for AMP was selectively inhibited by guanosine 5'-monophosphate, and its Vmax was several fold higher in a myelin-enriched fraction than in synaptosome-enriched fractions. The transport system with the Kt approximately 6 microM was selectively inhibited by alpha, beta-methylene adenosine diphosphate, and its Vmax was several times higher in a fraction enriched in high-density synaptosomes than in fractions enriched in low-density synaptosomes or myelin. Both of these transport systems were potently inhibited by ATP and ADP. Nucleotides that were either weak or inactive as inhibitors of AMP transport included 3'-AMP, cyclic AMP, guanosine 5'-diphosphate, and the 5'-mononucleotides of cytosine, inosine, and uridine. GTP consistently enhanced uptake at concentrations greater than or equal to 1 microM. The transport of AMP was not Na(+)-dependent and was not inhibited by membrane depolarization. This transport system may mediate the release of AMP for subsequent conversion to adenosine extracellularly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326723     DOI: 10.1007/bf00969887

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  Adenosine: The prototypic neuromodulator.

Authors:  M Williams
Journal:  Neurochem Int       Date:  1989       Impact factor: 3.921

Review 2.  Structure and function of A1 adenosine receptors.

Authors:  J Linden
Journal:  FASEB J       Date:  1991-09       Impact factor: 5.191

3.  Depolarization-evoked accumulation of cyclic AMP in brain slices: the requisite intermediate adenosine is not derived from hydrolysis of released ATP.

Authors:  F Pons; R F Bruns; J W Daly
Journal:  J Neurochem       Date:  1980-05       Impact factor: 5.372

4.  Changes in energy state and acid-base parameters of the rat brain during complete compression ischemia.

Authors:  B Ljunggren; H Schutz; B K Siesjö
Journal:  Brain Res       Date:  1974-06-20       Impact factor: 3.252

5.  Ion dependence of neurotransmitter uptake: inhibitory effects of ion substitutes.

Authors:  R P Shank; C R Schneider; J J Tighe
Journal:  J Neurochem       Date:  1987-08       Impact factor: 5.372

6.  Regional changes in the cellular level of adenine nucleotides in ischemic rat brain subjected to single embolization.

Authors:  K Yamada; T Uozumi; T Kawasaki; K Yamada; T Sogabe; K Ohta
Journal:  J Neurochem       Date:  1988-07       Impact factor: 5.372

7.  Adenosine transport by rat and guinea pig synaptosomes: basis for differential sensitivity to transport inhibitors.

Authors:  R P Shank; W J Baldy
Journal:  J Neurochem       Date:  1990-08       Impact factor: 5.372

8.  Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia.

Authors:  H Van Belle; F Goossens; J Wynants
Journal:  Am J Physiol       Date:  1987-05

9.  Glutamate-evoked release of endogenous adenosine from rat cortical synaptosomes is mediated by glutamate uptake and not by receptors.

Authors:  K Hoehn; T D White
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

Review 10.  Does ATP cross the cell plasma membrane.

Authors:  I H Chaudry
Journal:  Yale J Biol Med       Date:  1982 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.